RS56131196 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:Alzheimer's disease biomarkers]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Alzheimer's disease or family history of Alzheimer's disease | A | — | 8E-288 | PubMed |
| Alzheimer's disease | A | — | 2E-202 | PubMed |
| Low density lipoprotein cholesterol levels | G | OR: 0.16 | 6E-163 | PubMed |
| Total cholesterol levels | G | OR: 0.14 | 2E-120 | PubMed |
| High density lipoprotein cholesterol levels | G | β: 0.074 | 8E-53 | PubMed |
| Alzheimer's disease | — | OR: 3.21 | 4E-48 | PubMed |
| Homeobox protein MOX-1 levels | A | OR: 0.34 | 3E-33 | PubMed |
| Triglycerides | G | OR: 0.12 | 2E-32 | PubMed |
| Mean corpuscular hemoglobin concentration | A | β: 0.028 | 4E-27 | PubMed |
| Stromelysin-1 levels | A | OR: 0.27 | 1E-26 | PubMed |
| Memory decline | — | β: 0.016 | 4E-25 | PubMed |
| Mean corpuscular hemoglobin concentration | A | — | 7E-25 | PubMed |
| Alzheimer disease and age of onset | A | OR: 10.16 | 3E-24 | PubMed |
| Memory decline | — | β: 0.014 | 6E-23 | PubMed |
| Plasma p-tau181 levels | — | OR: 0.39 | 4E-22 | PubMed |
| Memory decline | — | β: 0.016 | 2E-21 | PubMed |
| Cerebral amyloid deposition (PET imaging) | A | OR: 0.14 | 1E-20 | PubMed |
| Memory decline | — | β: 0.015 | 8E-20 | PubMed |
| Baseline memory | — | OR: 0.12 | 6E-18 | PubMed |
| Visinin-like protein 1 (analyte X13522.20) levels | A | OR: 0.23 | 1E-17 | PubMed |